0001203311-23-000058.txt : 20230602 0001203311-23-000058.hdr.sgml : 20230602 20230602181940 ACCESSION NUMBER: 0001203311-23-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230531 FILED AS OF DATE: 20230602 DATE AS OF CHANGE: 20230602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SWAIN SANDRA M CENTRAL INDEX KEY: 0001908755 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 23990582 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0407 4 2023-05-31 0 0001060736 Seagen Inc. SGEN 0001908755 SWAIN SANDRA M 21823 30TH DRIVE S.E. BOTHELL WA 98021 1 0 0 0 0 Common Stock 2023-05-31 4 A 0 2044 0.0 A 2822 D These securities are restricted stock units and will be settled in common stock upon vesting. These restricted stock units shall vest in full on May 31, 2024. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Jennifer Prosba For: Sandra Swain 2023-06-02